Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer

被引：5
|
作者：
Takami, Hiroshi E. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan
来源：
ENDOCRINE JOURNAL | 2011年 / 58卷 / 03期
关键词：
Molecularly targeted drugs; Kinase inhibitors; Differentiated thyroid carcinoma; Medullary thyroid carcinoma; PHASE-II TRIAL; SORAFENIB; CARCINOMA;
D O I：
10.1507/endocrj.K11E-076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prognosis of almost all thyroid cancers is good, but some patients have indications for these molecularly targeted. drugs. Some of these drugs, i.e., vandetanib, XL-184, sorafenib, motesanib, axitinib, and pazopanib, are clearly useful clinically.
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [41] Advanced thyroid cancers: new era of treatment
    Mohammed, Amrallah A.
    EL-Shentenawy, Ayman
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [42] Individualized therapy of advanced stage thyroid cancer
    Spitzweg, C.
    Auernhammer, C.
    Lehner, S.
    Boeck, S.
    Heinemann, V.
    Werner, J.
    Angele, M. K.
    Bartenstein, P.
    ONKOLOGE, 2015, 21 (07): : 617 - +
  • [43] Molecular Targeted Therapies for Patients with Refractory Thyroid Cancer
    Chougnet, C.
    Brassard, M.
    Leboulleux, S.
    Baudin, E.
    Schlumberger, M.
    CLINICAL ONCOLOGY, 2010, 22 (06) : 448 - 455
  • [44] Current Molecular Targeted Agents for Advanced Gastric Cancer
    Nie, Shanshan
    Yang, Guoping
    Lu, Hongwei
    ONCOTARGETS AND THERAPY, 2020, 13 : 4075 - 4088
  • [45] Approach to the patient with advanced differentiated thyroid cancer
    Schlumberger, M.
    Sherman, S. I.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (01) : 5 - 11
  • [46] Current Status and Future Targeted Therapy in Adrenocortical Cancer
    Alyateem, George
    Nilubol, Naris
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [47] Gastric cancer in the era of molecularly targeted agents: current drug development strategies
    Arkenau, Hendrik-Tobias
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (07) : 855 - 866
  • [48] Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs
    Bousoik, Emira
    Nabiee, Ramina
    Amirrad, Farideh
    Nichols, Ashley
    Witt, Rebecca
    Mandipoor, Parvin
    Aliabadi, Hamidreza Montazeri
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Medical Therapy for Advanced Forms of Thyroid Cancer
    Rajhbeharrysingh, Uma
    Taylor, Matthew
    Milas, Mira
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (03) : 541 - +
  • [50] Second-Line Treatment for Advanced Thyroid Cancer: An Indication in Need of Randomized Clinical Trials
    Cohen, Aaron B.
    Brose, Marcia S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (06) : 1995 - 1997
12345